Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in Berlin, Germany. This
Dr. Lluís Puig moderates a panel discussion with experts Hervé Bachelez, Irène Gallais Sérézal, and Johann Gudjonsson, covering section one
Dr. Lluís Puig moderates a panel discussion with experts Axel Svedbom, Irène Gallais Sérézal, and Johann Gudjonsson, covering section two
Dr. Ronald Vender discusses TKY2 Inhibitors and explains their contribution to the initiation and chronicity of psoriasis.
Dr. Lluis Puig moderates a panel discussion with experts Richard Warren and Ronald Vender, covering section three lectures.
Dr. Lone Skov emphasizes the importance of real-world data in advancing psoriasis and its subtypes research, personalized medicine, and establishing
Dr. Catherine Smith discusses the science and practice, framework, and implementation of therapeutic drug monitoring (TDM).
Dr. Clause Zachariae explores Gunnar Lomholt’s role in advancing the field of psoriasis and his pioneering research in the Faroese
Dr. J. T. Elder discusses the genetic epidemiology of psoriasis, the evolution of genome-wide association studies (GWAS), the most recent
Dr. Tamar Nijisten discusses big data and its current and future implications for psoriasis research.
